NCT03381963View on ClinicalTrials.gov

Hemostatic Profiles of Endocrine Therapies for Breast Cancer

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

February 28, 2020

Study Completion Date

February 28, 2020

Conditions
Breast NeoplasmsVenous Thromboembolism
Trial Locations (1)

Unknown

Geneva University Hospitals, Geneva

All Listed Sponsors
lead

University Hospital, Geneva

OTHER

NCT03381963 - Hemostatic Profiles of Endocrine Therapies for Breast Cancer | Biotech Hunter | Biotech Hunter